Navigation Links
Zannos Grekos, MD to Present Clinical Results of Regenerative Stem Cell Treatments to the Dubai Congress on Anti-Aging and Aesthetic Medicine
Date:11/5/2008

Repair Stem Cell Institute touts Grekos' breakthrough in Biomedical Technology

WASHINGTON, Nov. 5 /PRNewswire/ -- The Repair Stem Cell Institute (RSCI; http://www.RepairStemCells.org) today announced that its Science Advisory Board member Zannos G. Grekos, MD, FAAP will present Emerging Frontiers in Regenerative Stem Cell Therapy: Current Clinical Experience with Autologus Adult Stem Cells in the Treatment of Various End Stage Diseases, at the 2008 Dubai Congress on Anti-Aging and Aesthetic Medicine (DCAAAM) in Dubai, United Arab Emirates on Saturday, November 8, 2008 at 3:00 p.m. UTC. According to RSCI Chairman Don Margolis, "Dr. Grekos is taking his groundbreaking work in regenerative biomedical technology to an international arena that has never before seen the dramatic clinical success achieved with his end-stage disease patients. RSCI is proud to have Dr. Grekos on its advisory board and there isn't a company or an institute in the world with the Repair Stem Cell treatment skills and experience that he and its other members bring."

In this Dubai presentation, Dr. Grekos will illustrate regenerated tissue and repaired function at six months and one year post-treatment with Adult Stem Cells. He will also present preliminary results from patients treated within several days through three month follow up. Results include the existence of viable myocardium where previously heart tissue had been destroyed and blood flow through new vessels generated by the injected Stem Cell population. "We have literally saved the lives of patients who prior to the development of Adult Stem Cell therapy, had no option available to them through medical science," states Grekos. "With a minimally invasive treatment, the risks of which are equal to a cardiac catheterization, we are more than doubling cardiac patients' ejection fraction, improving kidney and pulmonary function, saving limbs from amputation by creating new circulation pathways and most recently reversing the life-threatening effects of metabolic heart disease."

Dr. Grekos plans to also announce upcoming clinical trials with prospective candidates in currently untreated illness classifications, including several neurologically based diseases and macular degeneration.

Dr. Zannos Grekos is an Interventional Cardiologist with a private practice in Florida. He is Chief Medical Officer for Regenocyte Therapeutic, one of the world's leading Adult Stem Cell centers, and is Associate Clinical Professor of Cardiology for Nova Southeastern University. Having collaborated with major international treatment and research centers, he has been active in the development of both research and treatment protocols. In February 2007, he was invited to Washington DC to brief the United States Senate Health Advisory Staff on the current state of stem cell research and therapy.

Paul Schwartz, Chief Operating Officer for Regenocyte Therapeutic, states the company "is extremely pleased with the invitation to speak in Dubai. It is a symbol," Schwartz explains, "of the worldwide medical community's embrace of Dr. Grekos' forging of new territory and the notoriety Regenocyte is rapidly gaining through its amazing treatment results."

About the Repair Stem Cell Institute

The Repair Stem Cell Institute LLC (RSCI) is a global public service firm dedicated to educating the public about repair stem cell/adult stem cell research and treatments worldwide. RSCI was founded in April 2008 and is headquartered in Bangkok, Thailand with offices in Dallas, Texas and Washington, D.C.

About Regenocyte Therapeutic

Regenocyte(TM) Therapeutic LLC is one of the only clinically treating Adult Stem Cell Therapy centers in the world today. An experienced team of Board Certified physicians use cutting edge technology, paralleling that of Universities and major medical facilities, to prolong and improve the quality of life of patients living with diseases including Congestive Heart Failure, Cardiomyopathy, Peripheral Artery Disease, Coronary Artery Disease, Kidney Disease, Ischemic Heart Disease, Pulmonary Disease and Early Senile Dementia. For patient information or consultation, call 866-216-5710.


'/>"/>
SOURCE The Repair Stem Cell Institute
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
2. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
3. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
4. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
5. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
6. AtriCure to Present at Roth Capital Partners 2007 New York Conference
7. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
8. MDS to Present at Thomas Weisel Partners Healthcare Conference
9. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
10. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
11. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, ... ... School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, ... professionals on guideline updates for the primary prevention of cardiovascular diseases during ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional women, ... towards gender equality at their inaugural Summit in New York City in June. The ... social audience of over 3 million. To watch the Mobilize Women video, click ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... Mohebi Hair Restoration, has recently contributed a medical article to the newly revamped ... cosmetictown.com. Dr. Mohebi’s article spotlights the hair transplant procedure known as Follicular ...
Breaking Medicine News(10 mins):
(Date:10/7/2017)... 2017   Provista, a proven leader in ... in purchasing power, today announced a new resource area ... Newsroom is the online home for case studies, ... bios, news releases, slideshows and events. ... of resources at their fingertips, viewers can also watch ...
(Date:10/4/2017)... 4, 2017 OBP Medical , ... medical devices, today announced regulatory approval from ... (or Agência Nacional de Vigilância Sanitária (ANVISA)) to ... surgical retractor with integrated LED light source and ... and exposure of a tissue pocket or cavity ...
(Date:10/2/2017)... Halo Labs announces the European launch of their new low volume, ... 2017 in Cambridge, U.K on October 4th. ... samples with unprecedented speed and sensitivity while using far less sample ... ... system ...
Breaking Medicine Technology: